Arnold Etame, MD, PhD, discusses the effects of a patient’s socioeconomic status on the cancer treatment options they receive.
Arnold Etame, MD, PhD
Advertisement
Articles by Arnold Etame, MD, PhD
Immunotherapy is rapidly emerging as a very attractive and novel therapeutic approach for cancer, including for glioblastoma multiforme (GBM), the most common primary malignant brain tumor in adults.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on OncLive
1
FDA Approves Gedatolisib Plus Fulvestrant ± Palbociclib for Hormone Receptor–Positive, HER2-Negative, Locally Advanced/Metastatic Breast Cancer
2
FDA Awards Traditional Approval to Selpercatinib for RET+ Advanced Solid Tumors
3
Dr Cerchione on the FDA Approval of Subcutaneous Isatuximab in Myeloma
4
Research Rewind: Notable Phase 1/2 Breast Cancer Trial Readouts From Quarter 2 of 2026
5